Strategy

Quarter after quarter, year after year, Monet continues to be a leader in financial performance as measured against its peers. Sound strategy is a critical component of this success.

Monet invests exclusively in technology-related emerging growth companies in information technology and healthcare. This focus gives us a key advantage in identifying and evaluating new companies and products that offer potential for exceptional growth and profitability through fundamental advances in science and engineering. Our reputation for a strong technology orientation over the last 2 years has helped us establish an extensive network of entrepreneurs, industry experts, university researchers, government and financial leaders, and other venture capitalists.

We typically originate and lead initial syndications in the majority of our investments. The tremendous optional experience of our partners provides a valuable background for portfolio company involvement.

Once an investment has been syndicated, Monet remains active through board membership and helps in a variety of functional, strategic, and financial roles. In particular, we assist our portfolio companies in developing their management teams, refining their competitive strategies, and building their businesses - all in keeping with the firm's philosophy of collaborative, value-added investing.